VCRT.OB: Summary for VICOR TECHNOLOGIES - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 3:26am EST - Canadian Markets open in 6 hours and 4 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Vicor Technologies, Inc. (VCRT.OB)

On Nov 23: 0.69 USD 0.00 (0.00%)

MORE ON VCRT.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

VICOR TECHNOLOGIES (OTC BB:VCRT.OB) Delayed quote data

Last Trade:	0.69 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	0.69
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.25 - 1.30
Volume:	0
Avg Vol (3m):	16,013.8
Market Cap:	25.56M
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add VCRT.OB to Portfolio

Download Data

HEADLINES

•	VICOR TECHNOLOGIES, INC. Financials
	EDGAR Online Financials (Thu, Nov 19)

•	USAISR Researcher Dr. Andriy Batchinsky Identifies Vicor's PD2i(R) Nonlinear Algorithm as Most Promising Diagnostic for In-Field Trauma Triage in Presentation at the American Heart Association's Resuscitation Science Symposium 2009
	Marketwire (Thu, Nov 19)

•	Vicor Technologies Announces Filing of 10-Q on November 13, 2009
	Marketwire (Mon, Nov 16)

•	VICOR TECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	Trial Findings for Vicor Technologies' PD2i Vital Sign Diagnostic to Be Presented at the American Heart Association's Resuscitation Science Symposium 2009
	Marketwire (Tue, Oct 6)

•	Vicor Technologies Issued Australian Patent for Its Altered State Physiology Drug Development Platform
	Marketwire (Tue, Sep 29)

•	Vicor's PD2i to Be Tested on Trauma Patients in U.S. Army's New Critical Combat Care Engineering (C3E) Program Area
	Marketwire (Tue, Sep 22)

•	VICOR TECHNOLOGIES, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Tue, Sep 8)

•	Original Research Using Vicor Technologies' PD2i Algorithm Published in Therapeutics and Clinical Risk Management
	Marketwire (Tue, Aug 25)

•	VICOR TECHNOLOGIES, INC. Files SEC form 10-Q/A, Quarterly Report
	EDGAR Online (Wed, Aug 19)

More Headlines for VCRT.OB...

BUSINESS SUMMARY

Vicor Technologies, Inc., a biotechnology company, engages in the development of diagnostic and therapeutic products in the United States. Its diagnostic products are based on the company's patented PD2i algorithm, which is used to predict future ...

Full Company Profile

Add to Portfolio

Email to a Friend

•